MedPath

Dexmedetomidine in Pediatric Tonsillectomy

Phase 4
Completed
Conditions
Pediatric Adenotonsillectomy
Post Operative Analgesia
Interventions
Registration Number
NCT01057381
Lead Sponsor
Baylor College of Medicine
Brief Summary

The hypothesis of this study is that the administration of an intra-operative dose of dexmedetomidine will result in adequate analgesia without respiratory depression thereby resulting in an early discharge from the post anesthetic care unit following adenotonsillectomy.

Detailed Description

Dexmedetomidine, an alpha 2 agonist provides some analgesia without respiratory depression. Children undergoing tonsillectomy and adenoidectomy occasionally have episodes of respiratory obstruction in the recovery room following administration of opioids.

As dexmedetomidine provides some analgesia without respiratory depression,an intra-operative dose of dexmedetomidine may provide adequate analgesia without significant side effects thereby allowing for quick post operative recovery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
109
Inclusion Criteria
  • Children between ages 3 and 17 years with American Society of Anesthesiology classification 1 or 2.
Exclusion Criteria
  • Children less than 3 years
  • Children with uncorrected cardiac lesions
  • Children with heart block or liver impairment
  • Children with American Society of Anesthesiology Class 3 or 4.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Morphine 50 mcg/kgMorphine 50 mcg/kgIntra-operative administration of morphine 50 mcg/kg for analgesia
Morphine 100mcg/kgMorphine 100 mcg/kgIntra-operative administration of morphine 100mcg/kg for analgesia
Dexmedetomidine 0.75 mcg/kgDexmedetomidine 0.75 mcg/kgIntraoperative administration for analgesia.
Dexmedetomidine 1mcg/kgDexmedetomidine 1 mcg/kgIntra-operative administration of dexmedetomidine 1 mcg/kg for analgesia
Primary Outcome Measures
NameTimeMethod
Amount of Post-Operative Rescue Morphine Required for AnalgesiaFrom admission to discharge from PACU, up to 1 hour
Secondary Outcome Measures
NameTimeMethod
Morphine Rescue Doses Needed by ParticipantsFrom admission to discharge from PACU, up to 1 hour

Subjects with a Children's Hospital of Eastern Ontario Pain Scale score greater than 8 received rescue morphine doses of 25 ug/kg IV at 10-minute intervals until the score was less than 8.

Minimum and Maximum values: minimum score: 4 \& maximum score: 13. The higher the score ( \> 8), the greater the pain appreciated by the patient.

Duration of Oxygen SupplementationFrom admission to PACU until room air saturations greater than or equal to 95% for 5 minutes

The subjects were then transported to the PACU with supplemental oxygen. Oxygen administration was continued after extubation until the patient was awake and could sustain room air saturations greater than 95% for 5 minutes. Duration of oxygen requirement was recorded as the time from tracheal extubation to cessation of oxygen supplementation in the PACU.

Time to PACU Discharge ReadinessFrom admission to discharge from PACU, no time limit

Patients were considered ready for discharge from the PACU when they attained an Aldrete score of 9 or more and were free from pain, nausea, and vomiting. Aldrete score ranges form 0 to 10 and patients greater than 8 are deemed satisfactory for discharge from the PACU

Number of Participants With Emergence AgitationFrom admission to discharge from PACU, no time limit

Patients in the PACU who were crying, restless, disoriented, unresponsive to the parent's voice, with non-purposeful thrashing movements requiring additional personnel to prevent bodily harm, and inconsolable even after parental presence, rescue analgesia and additional measures of comfort were considered to have emergence agitation.

Number of Participants With Postoperative ComplicationsFrom admission to discharge from PACU, up to 1 hour

Post-operative complications including emesis, prolonged oxygen requirement or post- tonsillectomy bleed assessed up to 1 hour in PACU

Trial Locations

Locations (1)

Texas Children's Hospital, Baylor College of Medicine

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath